Telix Pharmaceuticals Limited (NASDAQ:TLX) Q1 2025 Earnings Call Transcript August 21, 2025
Telix Pharmaceuticals Limited misses on earnings expectations. Reported EPS is $-0.0068 EPS, expectations were $0.214.
Operator: Thank you for standing by, and welcome to the Telix Half Quarter 2025 Results and Investor Webcast. [Operator Instructions] I would now like to hand the conference over to Ms. Kyahn Williamson. Please go ahead.
Kyahn Williamson: Thank you and everybody, for joining us this...
